about
A locus for posterior polymorphous corneal dystrophy (PPCD3) maps to chromosome 10Ocular features in Alport syndrome: pathogenesis and clinical significanceDevelopmental distribution of collagen IV isoforms and relevance to ocular diseasesZeb1 mutant mice as a model of posterior corneal dystrophyInactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in miceRetinal basement membrane abnormalities and the retinopathy of Alport syndromeMutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cellsIdentification of microRNAs and their target genes in Alport syndrome using deep sequencing of iPSCs samples.Genetic linkage analysis of a novel syndrome comprising North Carolina-like macular dystrophy and progressive sensorineural hearing loss.Ocular manifestations of Alport syndromeDevelopment and application of a next-generation-sequencing (NGS) approach to detect known and novel gene defects underlying retinal diseases.A novel splice site mutation in the COL4A5 gene in a Chinese female patient with rare ocular abnormalitiesToric multifocal intraocular lens implantation in a case of bilateral anterior and posterior lenticonus in Alport syndromeClear lens phacoemulsification in the anterior lenticonus due to Alport Syndrome: two case reports.Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.Temporal macular thinning associated with X-linked Alport syndrome.The lens capsuleThe corneal epithelial basement membrane: structure, function, and disease.An Overlapping Case of Alport Syndrome and Thin Basement Membrane DiseaseAbnormal expression of collagen IV in lens activates unfolded protein response resulting in cataract.Giant macular hole in Alport syndrome.Alport syndrome--insights from basic and clinical research.Syndromes of hearing loss associated with visual loss.Lens capsule as a model to study type IV collagen.Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment.Bull's eye and pigment maculopathy are further retinal manifestations of an abnormal Bruch's membrane in Alport syndrome.The lens growth process.Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations.Retinal Findings on OCT in Systemic Conditions.Genotype-phenotype correlation in X-linked Alport syndromeProgressive posterior lenticonus in a patient with alport syndromeMacular hole in juvenile X-linked retinoschisis.Patterns of gene expression in microarrays and expressed sequence tags from normal and cataractous lensesMorning glory syndrome associated with posterior lenticonus.Renal, auricular, and ocular outcomes of Alport syndrome and their current management.Femtosecond laser-assisted cataract surgery in anterior lenticonus due to Alport syndrome.Spontaneous Anterior Lens Capsule Rupture Of a Patient with Alport Syndrome - A Case Report.[Bilateral visual loss in a young male patient].Elasticity of the porcine lens capsule as measured by osmotic swelling.Lens extrusion from Laminin alpha 1 mutant zebrafish
P2860
Q24533527-203DBA05-1957-48E2-A005-A7D3F729C617Q28080691-2F790959-FA90-4E50-95D6-FD6F12DFC4DCQ28509269-DA6CBBA3-35E7-444A-A073-1CC3D6EAA607Q28510771-BF88E718-9343-4BEF-A0E8-99E779B883BFQ28594288-07EAE4DA-438C-4AB3-BD92-FD609BE51F0FQ33845185-1EB0B88B-3603-4367-9297-87530FFCB105Q34106677-8166DA39-0C0B-4CB1-A70C-566F9F527E7DQ35170636-2DC0D09E-112C-4777-B8F2-FB32E0379DC4Q35591172-17E773D2-3E4A-4599-AE50-40DA6E61A12CQ35924065-BE712A7C-6363-483B-BC89-87B197F6BE97Q35959606-F022408A-FE35-432A-A06F-37BE76EFD8B3Q36182926-9853B583-D536-4B36-9943-93326A927A3BQ36221460-09D6DF0D-DAEC-45A5-8F7B-AB16972275B2Q36726685-36C40925-2C56-4AD6-9176-5EAE4C109901Q36810193-D60B312C-E5B0-472B-9F51-00F1E8B9D707Q37101426-19567201-C670-4D7B-916E-FBC9D23AA83CQ37171354-3C6E545C-1DCE-4D83-A4FC-1F7FC119B2A4Q37208901-7F170CAB-60A1-4E10-8F5E-00E83A7C420BQ37233987-2A46923C-C47A-48AE-AD4F-91A5C2F405A3Q37467727-A1562651-E0F2-4D7B-8ECA-87E166E58295Q37744970-5DDCBE73-49B0-4829-BB82-34645023FF63Q38061008-365686D3-9E26-425B-8852-5C3888B4E74DQ38103179-0FA54E9C-2784-4D21-A2EB-4E25AABE0BC1Q38179464-EDC9C256-6BA5-4938-844E-CCBC56E69E44Q38238367-0447DA39-DE71-458F-A7D7-683DBBDB109FQ38378944-91509AA3-D318-43C2-A61F-C01867F3F810Q38836230-A78D417A-4D00-4009-A3EC-F18B67FA08BBQ38994280-6CAE975C-4C0E-45E1-BD2C-3860DBC80F18Q39391134-1B2F9B1C-8F2D-4448-8897-1F680EB6FBC2Q40404388-957438AA-5DAD-41C9-8900-7B9A9090932BQ41534298-409B56BF-27B6-4E12-BAB0-E5B7FF332AC1Q41764782-45957D95-A533-418F-BA2E-C4E68A72D3C5Q41824732-226BE8D9-F8B9-4C89-8D39-3C28603DAF67Q42017496-BAB7D456-B7EB-4A85-892B-6BFBEFA6B784Q45871465-DC8448BB-C610-4C6B-B1E2-FC0BF754EFE4Q47101785-1E71E8C9-D096-4D87-8379-328E342459BFQ49382116-36389874-BF16-41A8-86AD-7DA76092E866Q50430873-F8D61D07-CC97-40CD-A298-166DA5E15B21Q50695710-3F4EC2A8-532D-4D17-90D8-EC11641E54F0Q51114688-B810F87A-DA30-4F6F-8C78-F8929DE1FC4A
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Alport syndrome. A review of the ocular manifestations.
@en
type
label
Alport syndrome. A review of the ocular manifestations.
@en
prefLabel
Alport syndrome. A review of the ocular manifestations.
@en
P2860
P1433
P1476
Alport syndrome. A review of the ocular manifestations.
@en
P2093
P2860
P304
P356
10.3109/13816819709041431
P577
1997-12-01T00:00:00Z